Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 9—September 2016
Letter

ESBL-Producing Strain of Hypervirulent Klebsiella pneumoniae K2, France

Cite This Article

To the Editor: Klebsiella pneumoniae is mainly responsible for hospital-acquired urinary tract infections, bacteremia, pneumonia and intra-abdominal infections. However, since the mid-1980s, K. pneumoniae has also been described as the cause of highly invasive community-acquired infections (1,2). The K. pneumoniae isolates associated with such infections are often hypermucoviscous and frequently belong to the capsular serotypes K1 or K2. Two of the most extensively studied genes associated with invasive infections are a mucoviscosity-associated gene A (magA) in serotype K1 and a regulator of mucoid phenotype A (rmpA). These strains of hypervirulent K. pneumoniae (hvKP) are now circulating worldwide (1,2).

At the same time, a substantial increase of high-level antimicrobial resistance acquired by non-hvKP strains has also been observed. Clonal complexes of hvKP and multidrug-resistant (MDR) strains had been considered independent (3) until 2014, when extended-spectrum β-lactamase (ESBL)– or carbapenemase-producing hvKP were first identified in China (4). Here we report an ESBL-producing strain of hvKP isolated from a patient in France.

The patient was a 56 year-old woman, born in Algeria, who alternately resided in France and Algeria for several years without travel to any other country. She underwent liver transplant in 2007 for primary biliary cirrhosis. In 2012, she had a routine posttransplant liver biopsy indicating granulomatosis, resulting in several examinations to determine its etiology. The patient was afebrile with no inflammatory syndrome. A thoracic computed tomography scan indicated no abnormalities. We performed a bronchoalveolar lavage, and bacteriologic examination of the specimen indicated a strain of K. pneumoniae with a hypermucoviscosity phenotype. We identified the ESBL phenotype with a positive double-disk synergy test between clavulanic acid and third-generation cephalosporins and aztreonam. We conducted antimicrobial susceptibility tests according to guidelines issued in 2013 by the Comité de l’Antibiogramme de la Société Française de Microbiologie (http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM2013vjuin.pdf). These tests revealed high-level resistance to third-generation cephalosporins and to all aminoglycosides except amikacin. The strain was susceptible to cefoxitin, piperacillin/tazobactam, carbapenems, all fluoroquinolones, fosfomycin, and trimethoprim/sulfamethoxazole. The patient did not receive any antimicrobial drug treatment and after 3 years of follow-up reported no signs of pneumopathy.

Multiplex PCR and sequencing of the identified strain indicated the presence of blaCTX-M-3 (5). We extracted plasmid carrying the ESBL gene with the DNA Plasmid Miniprep Kit (QIAGEN, Valencia, CA, USA) and transferred the gene by electroporation into Escherichia coli DH10B cells. Relaxase typing, which detects major replicon groups, revealed only IncL/M plasmid (6). We performed another multiplex PCR to determine capsular serotypes K1 or K2 and the presence of major virulence factors. The capsular serotype was K2 (7). We identified rmpA, the plasmid-mediated gene regulating extracellular polysaccharide synthesis, and iutA, entB, mrkD, and ybtS genes by this PCR test. The isolate belonged to sequence type (ST) 86 as determined by multilocus sequence typing (http://www.pasteur.fr/mlst).

The earliest-described strains of hvKP, which were isolated from liver abscesses, were predominantly serotype K1 and ST23 (2). The most frequently isolated non-K1 hvKP stains are currently serotype K2, known to cause hepatic abscesses and severe cases of pneumonia and other hvKP-associated infections such as necrotizing fasciitis (2). The K2 strains isolated to date appear to originate from a much broader range of ST groups that include ST86 and many others (e.g., ST65, ST66, ST373, ST374, ST375, ST380, and ST434) (8,9).

This patient, despite being immunocompromised, was only colonized with what is normally considered a highly pathogenic strain. In general, the acquisition of antimicrobial resistance genes reduces fitness, which could have been the case in this patient. However, other strains carrying MDR and high-virulence genes, namely E. coli ST131, have no loss in fitness (10). These clones might harbor other biologic factors providing a competitive advantage.

MDR strains of K. pneumoniae have emerged in recent years and have been identified as a major threat to public health by the US Centers for Disease Control and Prevention. hvKP, with its high pathogenic potential, has also been on the rise during the same period. In the past, MDR and hvKP strains evolved separately in distinct clonal groups (2), but the recent emergence of hvKP harboring the gene for MDR, such as the one identified in our study, raises newfound concerns. Our patient was colonized with an ST86 CTX-M-3–producing strain of K2 hvKP, raising the question of whether MDR hvKP strains could circulate in Europe.

Top

Acknowledgment

L.S. received funding from the Fondation pour la Recherche Médicale (grant no. DEA20140630021). A.B. received funding for postdoctoral research from SIDACTION.

Top

Laure SurgersComments to Author , Anders Boyd, Pierre-Marie Girard, Guillaume Arlet, and Dominique Decré

Author affiliations: Assistance Publique Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France (L. Surgers, P-M. Girard, G. Arlet, D. Decré); Université Pierre et Marie Curie, Sorbonne Universités, Paris (L. Surgers, A. Boyd, P-M. Girard, G. Arlet, D. Decré)

Top

References

  1. Decré  D, Verdet  C, Emirian  A, Le Gourrierec  T, Petit  JC, Offenstadt  G, Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol. 2011;49:30124. DOIPubMed
  2. Bialek-Davenet  S, Criscuolo  A, Ailloud  F, Passet  V, Jones  L, Delannoy-Vieillard  AS, Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20:181220. DOIPubMed
  3. McCabe  R, Lambert  L, Frazee  B. Invasive Klebsiella pneumoniae infections, California, USA. Emerg Infect Dis. 2010;16:14901. DOIPubMed
  4. Zhang  R, Lin  D, Chan  EW, Gu  D, Chen  GX, Chen  S. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. Antimicrob Agents Chemother. 2015;60:70911. DOIPubMed
  5. Dallenne  C, Da Costa  A, Decré  D, Favier  C, Arlet  G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:4905. DOIPubMed
  6. Compain  F, Poisson  A, Le Hello  S, Branger  C, Weill  FX, Arlet  G, Targeting relaxase genes for classification of the predominant plasmids in Enterobacteriaceae. Int J Med Microbiol. 2014;304:23642. DOIPubMed
  7. Compain  F, Babosan  A, Brisse  S, Genel  N, Audo  J, Ailloud  F, Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J Clin Microbiol. 2014;52:437780. DOIPubMed
  8. Lin  JC, Koh  TH, Lee  N, Fung  CP, Chang  FY, Tsai  YK, Genotypes and virulence in serotype K2 Klebsiella pneumoniae from liver abscess and non-infectious carriers in Hong Kong, Singapore and Taiwan. Gut Pathog. 2014;6:21. DOIPubMed
  9. Struve  C, Roe  CC, Stegger  M, Stahlhut  SG, Hansen  DS, Engelthaler  DM, Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio. 2015;6:e00630. DOIPubMed
  10. Schaufler  K, Semmler  T, Pickard  DJ, de Toro  M, de la Cruz  F, Wieler  LH, Carriage of extended-spectrum beta-lactamase-plasmids does not reduce fitness but enhances virulence in some strains of pandemic E. coli lineages. Front Microbiol. 2016;7:336. DOIPubMed

Top

Cite This Article

DOI: 10.3201/eid2209.160681

Related Links

Top

Table of Contents – Volume 22, Number 9—September 2016

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Laure Surgers, Service de Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75012 Paris, France

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external